ARCHIVES

NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies

This article is from The Cancer Letter archive.

Vol. 25 No. 30 | July 30, 1999

Download PDF Visit The Full Archive

Related Articles

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

Partial Responses To Zactima In Thyroid Cancer Trial

January 27, 2006

French Legion d’Honneur Bestowed On Hortobagyi.

March 1, 2002

Group Chairs: Research In “Crisis” ASCO Says NCTN Budgets Cut By 40 Percent, Warns of “Dangerous Disruption of Cancer Care”

April 4, 2014

16 Institutions Win NCI Awards for Phase I Trials

May 2, 2003